Michael B. Hoffman - 18 Jan 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director, 10%+ Owner
Signature
/s/ Henry Hagopian III, Attorney-in-Fact for Michael Hoffman
Issuer symbol
ANVS
Transactions as of
18 Jan 2023
Net transactions value
$0
Form type
4
Filing time
20 Jan 2023, 16:38:36 UTC
Previous filing
05 Jan 2022
Next filing
11 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +6,820 $0.000000 6,820 18 Jan 2023 Common Stock 6,820 $13.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.